Akari Therapeutics, Plc
AKTX
$1.21
$0.1059.55%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -3.77M | -2.90M | -7.56M | -5.57M | -4.14M |
| Total Depreciation and Amortization | 1.00K | 0.00 | 0.00 | 13.00K | 1.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 104.00K | 59.00K | 612.00K | -89.00K | -465.00K |
| Change in Net Operating Assets | 1.54M | 1.35M | 2.05M | 1.60M | 193.00K |
| Cash from Operations | -2.12M | -1.49M | -4.89M | -4.04M | -4.41M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 382.00K | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 382.00K | -- | -- | -- | -- |
| Total Debt Issued | -3.00K | 29.00K | 1.00M | -- | -1.00K |
| Total Debt Repaid | -973.00K | -336.00K | -331.00K | -215.00K | -- |
| Issuance of Common Stock | 3.13M | -- | 7.09M | 1.73M | 3.52M |
| Repurchase of Common Stock | -- | -136.00K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2.15M | -443.00K | 7.76M | 1.51M | 3.52M |
| Foreign Exchange rate Adjustments | 1.00K | 2.00K | -2.00K | -5.00K | 6.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 413.00K | -1.93M | 2.87M | -2.54M | -886.00K |